Nuclera Nucleics Limited – Trademark Portfolio
Entity Type: 99
Nuclera Nucleics Limited holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 3 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 4 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include EDNA, EGENE, and EPROTEIN. The owner is based in Cambridge.
137 Cambridge Science Park, Milton Road
Cambridge CB40GD
Showing of trademarks Trademarks
Trademark Classifications
Nuclera Nucleics Limited's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Nuclera Nucleics Limited have?
Nuclera Nucleics Limited has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does Nuclera Nucleics Limited file in?
Nuclera Nucleics Limited files trademarks across 4 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Nuclera Nucleics Limited's most well-known trademarks?
Nuclera Nucleics Limited's registered trademark portfolio includes well-known marks such as EDNA, EGENE, and EPROTEIN. These are among 3 currently registered trademarks in the portfolio.
What is Nuclera Nucleics Limited's trademark registration success rate?
Nuclera Nucleics Limited has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.